Carisma to lay off staff, drop clinical CAR-M program in favor of second candidate
Carisma Therapeutics disclosed Monday that it is pausing development of two cell therapy candidates and planning to cut its workforce by …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
